CD4 and acute lymphoblastic leukemia: At 4 weeks after transplant, there was a statistically significant 66% reduction in percentage of CD4+CD8+ T-ALL blasts in the blood of doxycycline-treated mice in contrast to placebo-treated mice (Fig. 6A, B).